IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
UP-0145983
(2005-06-07)
|
등록번호 |
US-7556150
(2009-07-15)
|
발명자
/ 주소 |
- Reape, Kathy
- Jones, George
|
출원인 / 주소 |
- Duramed Pharmaceuticals, Inc.
|
대리인 / 주소 |
Sterne, Kessler, Goldstein & Fox P.L.L.C.
|
인용정보 |
피인용 횟수 :
1 인용 특허 :
31 |
초록
▼
A dispenser including a first dispensing portion including one group of storage units for each of ten to twenty-eight days, and a second dispensing portion, including at least one storage unit for each of seventeen to thirty days. In the first dispensing portion, a first set includes a group of four
A dispenser including a first dispensing portion including one group of storage units for each of ten to twenty-eight days, and a second dispensing portion, including at least one storage unit for each of seventeen to thirty days. In the first dispensing portion, a first set includes a group of four storage units for each day, a second set includes a group of three storage units for each day, and a third set includes a group of two storage units for each day. The first dispensing portion contain a progestin. In the second dispensing portion, the first fourteen storage units contain a placebo and the remaining storage units contain a progestin. First and second dispensing portions may be provided as separate dispensing packs, or as a multi-pack of second dispensing portions. The dispenser is useful for treatment of acute episodes of dysfunctional uterine bleeding (DUB) and maintenance treatment for preventing future episodes of DUB.
대표청구항
▼
What is claimed is: 1. A dispenser for an oral dosage form of a pharmaceutical, comprising: a first dispenser pack corresponding to a treatment regimen, including a plurality of storage units, including a group of storage units for each day of the treatment regimen, wherein each storage unit includ
What is claimed is: 1. A dispenser for an oral dosage form of a pharmaceutical, comprising: a first dispenser pack corresponding to a treatment regimen, including a plurality of storage units, including a group of storage units for each day of the treatment regimen, wherein each storage unit includes the same dosage of a pharmaceutical, and wherein each group of storage units is labeled with an indicator so as to identify when the pharmaceutical should be administered, wherein said indicators are such that the number of storage units identified for a first treatment day is greater than the number of storage units identified for a second treatment day, the number of storage units identified for each of a third and fourth treatment day is the same as the number of storage units identified for said second treatment day, the number of storage units identified for said fourth treatment day is greater than the number of storage units identified for a fifth treatment day, and the number of storage units identified for each day of a sixth through fourteenth treatment day is equal to the number of storage units identified for said fifth treatment day; at least one second dispenser pack corresponding to a maintenance treatment regimen, including a plurality of storage units, including a single storage unit for each day of said maintenance treatment regimen, wherein for each day of a first through fourteenth treatment day, a placebo or health supplement is included in said storage unit, and wherein, for each day of a fifteenth through twenty-fourth treatment day, a dosage of a pharmaceutical is included in the storage unit, said dosage of said pharmaceutical being the same on each of said fifteenth through twenty-fourth treatment days. 2. The dispenser as set forth in claim 1, wherein at least some of said storage units are blisters. 3. The dispenser as set forth in claim 1, wherein said first dispenser pack includes a total of fourteen treatment days. 4. The dispenser as set forth in claim 3, wherein said indicators are such that four storage units are identified for said first treatment day of said first dispenser pack. 5. The dispenser as set forth in claim 4, wherein said indicators are such that three storage units are identified for each of said second, third, and fourth treatment days of said first dispenser pack. 6. The dispenser as set forth in claim 5, wherein said indicators are such that two storage units are identified for each of said fifth through fourteenth treatment days of said first dispenser pack. 7. The dispenser as set forth in claim 6, wherein each storage unit in said first dispenser pack contains an oral dosage form of a progestin. 8. The dispenser as set forth in claim 7, wherein said oral dosage form of a progestin is norethindrone acetate or medroxyprogesterone acetate. 9. The dispenser as set forth in claim 8, wherein said oral dosage form of a progestin is 5 mg of norethindrone acetate or 10 mg of medroxyprogesterone acetate. 10. The dispenser as set forth in claim 1, wherein said health supplement is iron, folic acid or calcium. 11. The dispenser as set forth in claim 1, wherein an oral dosage form of a progestin is included in the storage unit for each of said fifteenth through twenty-fourth treatment days of each said second dispenser pack. 12. The dispenser as set forth in claim 1, wherein each said second dispenser pack includes a total of twenty-four storage units. 13. The dispenser as set forth in claim 11, wherein said oral dosage form of a progestin is norethindrone acetate or medroxyprogesterone acetate. 14. The dispenser as set forth in claim 13, wherein said oral dosage form of a progestin is 5 mg of norethindrone acetate or 10 mg of medroxyprogesterone acetate. 15. The dispenser as set forth in claim 1, wherein each storage unit in said first dispenser pack contains one of 20 mg of norethindrone acetate or 40 mg of medroxyprogesterone acetate. 16. The dispenser as set forth in claim 1, wherein each storage unit in said first dispenser pack contains one of 15 mg of norethindrone acetate or 30 mg of medroxyprogesterone acetate. 17. The dispenser as set forth in claim 1, wherein each storage unit in said first dispenser pack contains one of 10 mg of norethindrone acetate or 20 mg of medroxyprogesterone acetate. 18. The dispenser as set forth in claim 1, wherein at least one of said indicators for at least one group of storage units includes an indicium for each storage unit in the group. 19. The dispenser as set forth in claim 18, wherein the indicium for each storage unit is a time-of-day indicator. 20. The dispenser as set forth in claim 1, wherein said dispenser includes at least two second dispenser packs. 21. The dispenser as set forth in claim 1, wherein at least one of said first dispenser pack and said second dispenser pack is a blister pack. 22. The dispenser as set forth in claim 1, wherein said first dispenser pack and said second dispenser pack are separate blister packs.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.